Key result
Longer in-stent restenosis lesions treated with brachytherapy had a significantly greater increase in maximum intimal hyperplasia area at follow-up compared to shorter lesions (P=0.0006).
Why the study?
Does lesion length impact the efficacy of intracoronary γ-irradiation for preventing recurrent in-stent restenosis?
Cohort (n=66)
Does lesion length impact the efficacy of intracoronary γ-irradiation for preventing recurrent in-stent restenosis?
p-value: p=0.0006
Brachytherapy may be less effective in longer in-stent restenosis lesions due to greater variability and longer source-to-target distances in diffuse ISR.
Longer ISR lesions may respond less to brachytherapy; hypothesis-generating for lesion-specific dosing strategies.
BACKGROUND: The relation between lesion length and effectiveness of brachytherapy is not well studied. METHODS AND RESULTS: We compared serial (postintervention and follow-up) intravascular ultrasound findings in 66 patients with native coronary artery in-stent restenosis (ISR) who were treated with (192)Ir (15 Gy delivered 2 mm away from the radiation source). Patients were enrolled in the Washington Radiation for In-Stent Restenosis Trial (WRIST; ISR length, 10 to 47 mm; n=36) or Long WRIST (ISR length, 36 to 80 mm; n=30). External elastic membrane, stent, lumen, and intimal hyperplasia (IH; stent minus lumen) areas and source-to-target (intravascular ultrasound catheter to external elastic membrane) distances were measured. Postintervention stent areas were larger in WRIST and smaller in Long WRIST patients (P:<0.0001). At follow-up, maximum IH area significantly increased in both WRIST and Long WRIST patients (P:<0.0001 for both), but this increase was greater in Long WRIST patients (P:=0.0006). Similarly, minimum lumen cross-sectional area significantly decreased in both WRIST and Long WRIST patients (P:<0.05 and P:<0.0001, respectively), but this decrease was more pronounced in Long WRIST patients (P:=0.0567). The maximum source-to-target distance was longer in Long WRIST than in WRIST, and it correlated directly with ISR length (r=0.547, P:<0.0001). Overall, the change in minimum lumen area and the change in maximum IH area correlated with the maximum source-to-target distance (r=0.352, P:=0.0038 and r=0.523, P:<0.0001 for WRIST and Long WRIST, respectively). The variability (maximum/minimum) in IH area at follow-up also correlated with the maximum source-to-target distance (r=0.378, P:<0.0001). CONCLUSIONS: Brachytherapy may be less effective in longer ISR lesions because of the greater variability and longer source-to-target distances in diffuse ISR.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2001) conducted a cohort in native coronary artery in-stent restenosis (ISR) (n=66). Longer in-stent restenosis lesions (36 to 80 mm) vs. Shorter in-stent restenosis lesions (10 to 47 mm) was evaluated on Increase in maximum intimal hyperplasia (IH) area at follow-up (p=0.0006). Longer in-stent restenosis lesions treated with brachytherapy had a significantly greater increase in maximum intimal hyperplasia area at follow-up compared to shorter lesions (P=0.0006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: